KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.29% | -9.13% | -11.15% | -13.00% | -10.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.56% | 1.26% | -8.93% | 4.26% | 16.96% |
| Operating Income | 9.56% | -1.26% | 8.93% | -4.26% | -16.96% |
| Income Before Tax | 24.22% | 5.24% | -2.83% | 8.01% | 18.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.22% | 5.24% | -2.83% | 8.01% | 18.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.22% | 5.24% | -2.83% | 8.01% | 18.32% |
| EBIT | 9.56% | -1.26% | 8.93% | -4.26% | -16.96% |
| EBITDA | 9.63% | -1.28% | 8.84% | -4.47% | -17.20% |
| EPS Basic | 66.41% | 45.25% | 43.33% | 27.51% | 39.92% |
| Normalized Basic EPS | 66.03% | 4.56% | 55.01% | 24.70% | 33.26% |
| EPS Diluted | 66.41% | 45.25% | 43.33% | 27.51% | 39.96% |
| Normalized Diluted EPS | 66.03% | 4.56% | 55.01% | 24.70% | 33.26% |
| Average Basic Shares Outstanding | 125.58% | 73.07% | 81.46% | 26.90% | 35.96% |
| Average Diluted Shares Outstanding | 125.58% | 73.07% | 81.46% | 26.90% | 35.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |